Alessandro Rocco

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention

Maurizio Paciaroni, Giancarlo Agnelli, Valeria Caso et al. · Stroke · 2019 · 96 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

IV thrombolysis and statins

Stefan T. Engelter, Lauri Soinne, Peter A. Ringleb et al. · Neurology · 2011 · 74 citations

Pharmacy, Pharmacotherapy, Good Clinical Practice +16

Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy

Simona Sacco, Stefano Ricci, Raffaele Ornello et al. · Stroke · 2020 · 74 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study

Maurizio Paciaroni, Valeria Caso, Giancarlo Agnelli et al. · Stroke · 2022 · 73 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17